Jagsonpal Pharmaceuticals standalone net profit declines 65.77% in the December 2025 quarter
Sales decline 1.46% to Rs 72.95 crore
Net profit of Jagsonpal Pharmaceuticals declined 65.77% to Rs 10.95 crore in the quarter ended December 2025 as against Rs 31.99 crore during the previous quarter ended December 2024. Sales declined 1.46% to Rs 72.95 crore in the quarter ended December 2025 as against Rs 74.03 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales72.9574.03 -1 OPM %22.3021.38 -PBDT18.9917.90 6 PBT16.6015.49 7 NP10.9531.99 -66Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content